Skip to main content
Equibles

MORGAN STANLEY

Position in PMCB — PharmaCyte Biotech, Inc.

CIK 895421 NEW YORK, NY
Back to PMCB Full portfolio

Position in PMCB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2
+$1 QoQ
Shares Held
2
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 30 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in PMCB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. PMCB ranks #518 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in PMCB

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2 2
2026-03-31 $1 1
2025-12-31 $2 2
2025-09-30 $7 9
2025-06-30 $1 1
2025-03-31 $1 1
2024-12-31 $3 2
2024-09-30 $3 2
2024-06-30 $5 3
2024-03-31 $6 3
2023-12-31 $8 4
2023-09-30 $6 3
2023-06-30 $59 21
2023-03-31 $90 31
2022-12-31 $161 55
2022-09-30 $74 31
2022-06-30 $5,657 2,526
2022-03-31 $142,298 61,869
2021-12-31 $170,332 68,133
2021-09-30 $4,276 1,349